Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust & False Advertising Suits Against Divis...
19 2월 2014 - 1:24AM
Marketwired
Decision Diagnostics Announces Agreement for Funding of Its
Prosecution of Anti-Trust and False Advertising Suits Against
Division of Johnson & Johnson
Fresh From the Court Ruling on Its GenStrip Product, DECN Pivots
From Defense to Offense to Prosecute Johnson & Johnson in Two
Countersuits
DECN to Seek Triple Damages and Readies Attack on $12.7M Court
Ordered Bond
LOS ANGELES, CA--(Marketwired - Feb 18, 2014) - Decision
Diagnostics Corp. (OTCQB: DECN), the exclusive worldwide sales,
service and regulatory processes agent for the popular Shasta
GenStrip™, the unique Green Glucose Test Strip, specifically
designed to work with the Johnson & Johnson's LifeScan
Ultra family of glucose testing meters, today announced that that
the Company has executed a Terms Agreement with a major east coast
based litigation prosecution fund for the financing of the
prosecution of DECN's countersuits brought against LifeScan, Inc.,
a division of Johnson and Johnson, Inc. DECN has asserted
claims for anti-trust violations and false advertising.
"The antitrust prosecution, if successful, carries with it a
possible award of triple damages," said Keith Berman, DECN's
Principal Executive Officer and the GenStrip Program
Director. Mr. Berman further observed, "In our case, we are
pursuing two prizes simultaneously, first the prosecution of our
anti-trust and false advertising claims for J&J's
anti-competitive behavior throughout our dispute, and secondly, we
will assemble our arguments and begin a process of collecting on
the damages we have suffered as the result of the J&J patent
litigation on which the Court of Appeals for the Federal Circuit
has ruled favorably for DECN. This higher court ruling offers DECN
an opportunity to begin prosecution efforts, an upcoming attack as
some have called it, on the $12.7 million court ordered litigation
bond. Our litigation financing partner has put up a substantial
pool of capital specifically to assist us in achieving significant
positive outcomes for these prosecutions."
In the meantime, the company reminds shareholders and all
interested parties that it is currently airing its GenStrip
commercial video titled, "A Winter Patchwork" in every region of
the country, and has secured play times on all cable outlets that
will televise the 2014 Winter Olympics. The company's media
schedule calls for almost 13,000 total 30 second buys with the
commercial playing all hours of the day except for late morning and
dinner hours. The extremely popular video is available for viewing
at: http://shastagenstrip.com/winter_ad.html or
http://youtu.be/j0njOGSSKtQ.
Mr. Berman concluded, "The most recent court rulings favor
DECN's position and the company now has all of the additional
financing required, and then some, to contest an expensive, but
potentially benefit rich, two front legal battle."
Forward Looking Statements:
This release contains forward-looking statements about our
business or financial condition that reflect our assumptions and
beliefs based on information currently available. We can give no
assurance that the expectations indicated by such forward-looking
statements will be realized. There may be other risks and
circumstances that we are unable to predict. When used in this
release, words such as "believes," "expects," "forecasts,"
"intends," "projects," "plans," "anticipates," "estimates" and
similar expressions are intended to identify forward-looking
statements, although there may be certain statements not
accompanied by such expressions.
For further information about Shasta GenStrip, please visit the
company's Web Sites: http://www.decisiondiagnostics.com/ or
http://www.shastagenstrip.com/.
GenStrip™ test strips are a product of Shasta Technologies, LLC
and are not manufactured, distributed, endorsed, or approved by nor
associated with LifeScan®, Inc. a Johnson & Johnson® Company,
manufacturers and distributors of the OneTouch® Ultra® Family of
Meters and OneTouch® Ultra® test strips.
Contact: Decision Diagnostics Corp. Keith Berman (805) 446-2973
info@decisiondiagnostics.com
Decision Diagnostics (CE) (USOTC:DECN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Decision Diagnostics (CE) (USOTC:DECN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024